A multinational pharmaceutical company with broad manufacturing capabilities was considering horizontally expanding their portfolio to include biosimilars. Kineticos was charged with providing a detailed analysis of the market opportunity for two unique biosimilar licensing opportunities, as well as any gaps with respect to resource requirements that such an expansion would necessitate.
NOTE: Use your cursor or the tool-bar located at the bottom to review all available pages, including example deliverables.
To download the full case study including example deliverables, click here: In-Licensing
Subscribe to the Kineticos Research Institute to receive weekly emails containing insightful content.